A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...

Demand for Mounjaro cannot realistically be metType 2 diabetes medication Mounjaro is less than a week away from being ...

It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and Orlistat.

Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...

FROM nausea to constipation and life-threatening pancreatitis, fat jabs come with a long list of possible side effects. But, ...

It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and ...

A phased rollout of Mounjaro is set to begin across the UK next week as GP surgeries issue an urgent warning to patients.

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

General practitioners across the NHS are urging patients to cease requests for weight loss injections as they prepare for the ...

WEIGHT loss jabs, including Mounjaro and Wegovy, have been linked to more than 100 deaths in the UK, new figures have revealed. But none of the fatalities are proven to have been caused directly ...

A total of 111 deaths were logged with the regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), up to ...